The co-occurrence of extra-nucleolar CYCLON localization and a pan-cellular NPM1 pattern represents a strong predictor of poor prognosis in DLBCL, specifically associated with refractory disease. This evidence concerns the gene CCDC86 and diffuse large B-cell lymphoma.